Protein Summary
Cytokine that may play an important role during carcinogenesis and metanephric kidney organogenesis, as a BMP antagonist required for early limb outgrowth and patterning in maintaining the FGF4-SHH feedback loop. Down-regulates the BMP4 signaling in a dose-dependent manner (By similarity). Antagonist of BMP2; inhibits BMP2-mediated differentiation of osteoblasts (in vitro) (PubMed:27036124). Acts as inhibitor of monocyte chemotaxis. Can inhibit the growth or viability of normal cells but not transformed cells when is overexpressed (By similarity). This gene encodes a member of the BMP (bone morphogenic protein) antagonist family. Like BMPs, BMP antagonists contain cystine knots and typically form homo- and heterodimers. The CAN (cerberus and dan) subfamily of BMP antagonists, to which this gene belongs, is characterized by a C-terminal cystine knot with an eight-membered ring. The antagonistic effect of the secreted glycosylated protein encoded by this gene is likely due to its direct ...more
- ENST00000560830
- ENSP00000453141
- ENSG00000166923
- ENST00000622074
- ENSP00000478319
- ENST00000632478
- ENSP00000488158
- ENSG00000282046
- ENST00000632802
- ENSP00000488588
- CKTSF1B1
- DAND2
- DRM
- DRM
- HMPS
- MPSH
- PIG2
- CRAC1
- CRCS4
- DAND2
- HMPS1
- IHG-2
- DUP15q
- C15DUPq
- GREMLIN
- CKTSF1B1
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
biological process | 1 | ||
PubMedID | 0.83 | ||
molecular function | 0.81 | ||
gene perturbation | 0.73 | ||
biological term | 0.71 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 588.79 (req: < 5)
Gene RIFs: 148 (req: <= 3)
Antibodies: 514 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 588.79 (req: >= 5)
Gene RIFs: 148 (req: > 3)
Antibodies: 514 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 50
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0